- Report
- May 2023
- 140 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- April 2023
- 147 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- April 2023
- 147 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- November 2022
- 119 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- November 2022
- 107 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Report
- October 2021
- 54 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- October 2023
- 71 Pages
Global
From €3500EUR$4,249USD£3,133GBP
- Report
- August 2024
- 240 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- February 2020
- 44 Pages
Asia Pacific
From €3084EUR$3,495USD£2,667GBP
- Newsletter
- September 2025
- 2 Pages
Global
From €116EUR$131USD£100GBP
- Report
- May 2022
- 46 Pages
Global
From €1765EUR$2,000USD£1,526GBP
- Report
- September 2025
Europe
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
Global
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
China
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
United States
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
North America
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
Europe
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
Middle East
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- September 2025
Asia Pacific
From €1849EUR$2,095USD£1,599GBP
€3521EUR$3,990USD£3,045GBP
- Report
- October 2023
- 146 Pages
Global
From €3113EUR$3,528USD£2,692GBP
€3662EUR$4,150USD£3,167GBP

The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue.
Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection.
Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more